MDxHealth Statistics
Total Valuation
MDxHealth has a market cap or net worth of $57.24 million. The enterprise value is $143.88 million.
| Market Cap | 57.24M |
| Enterprise Value | 143.88M |
Important Dates
The next confirmed earnings date is Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MDxHealth has 95.42 million shares outstanding. The number of shares has increased by 13.74% in one year.
| Current Share Class | 95.42M |
| Shares Outstanding | 95.42M |
| Shares Change (YoY) | +13.74% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 7.44% |
| Owned by Institutions (%) | 50.04% |
| Float | 78.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.50 |
| Forward PS | 0.48 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.15
| Current Ratio | 1.15 |
| Quick Ratio | 0.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.66 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -9.83% |
| Return on Invested Capital (ROIC) | -16.91% |
| Return on Capital Employed (ROCE) | -22.66% |
| Weighted Average Cost of Capital (WACC) | -1,000,368.33% |
| Revenue Per Employee | $313,253 |
| Profits Per Employee | -$102,574 |
| Employee Count | 364 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 8.39 |
Taxes
| Income Tax | -1.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.53% in the last 52 weeks. The beta is -518,218.96, so MDxHealth's price volatility has been lower than the market average.
| Beta (5Y) | -518,218.96 |
| 52-Week Price Change | -87.53% |
| 50-Day Moving Average | 0.62 |
| 200-Day Moving Average | 1.80 |
| Relative Strength Index (RSI) | 47.16 |
| Average Volume (20 Days) | 205,784 |
Short Selling Information
The latest short interest is 1.52 million, so 1.83% of the outstanding shares have been sold short.
| Short Interest | 1.52M |
| Short Previous Month | 1.54M |
| Short % of Shares Out | 1.83% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.69 |
Income Statement
In the last 12 months, MDxHealth had revenue of $114.02 million and -$37.34 million in losses. Loss per share was -$0.74.
| Revenue | 114.02M |
| Gross Profit | 71.67M |
| Operating Income | -21.46M |
| Pretax Income | -38.01M |
| Net Income | -37.34M |
| EBITDA | -14.93M |
| EBIT | -21.46M |
| Loss Per Share | -$0.74 |
Balance Sheet
The company has $19.21 million in cash and $105.85 million in debt, with a net cash position of -$86.64 million or -$0.91 per share.
| Cash & Cash Equivalents | 19.21M |
| Total Debt | 105.85M |
| Net Cash | -86.64M |
| Net Cash Per Share | -$0.91 |
| Equity (Book Value) | -30.40M |
| Book Value Per Share | -0.59 |
| Working Capital | 5.63M |
Cash Flow
In the last 12 months, operating cash flow was -$5.30 million and capital expenditures -$718,000, giving a free cash flow of -$6.02 million.
| Operating Cash Flow | -5.30M |
| Capital Expenditures | -718,000 |
| Depreciation & Amortization | 6.53M |
| Net Borrowing | 16.72M |
| Free Cash Flow | -6.02M |
| FCF Per Share | -$0.06 |
Margins
Gross margin is 62.86%, with operating and profit margins of -18.82% and -32.74%.
| Gross Margin | 62.86% |
| Operating Margin | -18.82% |
| Pretax Margin | -33.33% |
| Profit Margin | -32.74% |
| EBITDA Margin | -13.09% |
| EBIT Margin | -18.82% |
| FCF Margin | n/a |
Dividends & Yields
MDxHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -13.74% |
| Shareholder Yield | -13.74% |
| Earnings Yield | -65.23% |
| FCF Yield | -10.51% |
Analyst Forecast
The average price target for MDxHealth is $1.80, which is 200.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $1.80 |
| Price Target Difference | 200.05% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 9.00% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MDxHealth has an Altman Z-Score of -3.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.57 |
| Piotroski F-Score | 2 |